Skip to main content
Equibles

Creek Drive Management Group LLC

Position in QURE — uniQure N.V.

CIK 2111824 SAN FRANCISCO, CA
Back to QURE Full portfolio

Position in QURE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,522,220
+$13,069,720 QoQ
Shares Held
337,000
+124.7% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
9.71%
of 13F equity value
Holder Rank
#45
of 255 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Jun 30, 2026
CallValue
$2,303,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creek Drive Management Group LLC holds $57,997,020 across 7 Biotechnology names. QURE ranks #3 (26.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 157,500 $20,988,450
2 NKTR
Nektar Therapeutics
 243,000 $16,963,830
3 QURE
uniQure N.V.
This page 		337,000 $15,522,220
4 RNA
Atrium Therapeutics, Inc.
 127,600 $1,716,220
5 TENX
Tenax Therapeutics, Inc.
 74,000 $1,076,700
6 PALI
Palisade Bio, Inc.
 440,000 $919,600
7 PEPG
PepGen Inc.
 450,000 $810,000

All Filings in QURE

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,303,000 50,000
2026-06-30 $15,522,220 337,000
2026-03-31 $2,452,500 150,000
2026-03-31 $817,500 50,000
2025-12-31 $779,715 300,000